KFDA to designate tadalafil-containing preparations having possible abuse and misuse of medicine

Published: 2003-08-20 06:58:00

Updated: 2003-08-20 06:58:00

The Korea Food and Drug Administration announced on August 19 that tadalafil-containing preparations for the treatment of erectile dysfunction will be additionally designated as the possible abuse and misuse of medicines, according to the proposed rules concerning the designation of possible abus...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK